Pharmacist’s Conviction for Unlawful Distribution of Controlled Drugs Leads to Continued Suspension
Date of Decision: February 23, 2023
Registrant's Role: Pharmacist
Outcome: Suspension (12 months) with review
GPhC Standards Breached: Risk to the public Brought the profession into disrepute Breached the fundamental principles of pharmacy Integrity could not be relied upon
Case Summary
In a recent determination by the General Pharmaceutical Council (GPhC) Fitness to Practise Committee, a pharmacist was found to have impaired fitness to practise due to a conviction for the unlawful distribution of controlled drugs. The case, which was reviewed on February 23, 2023, involved the registrant’s conviction for possessing and supplying controlled drugs without a valid Home Office license. The registrant, who was the director of a company operating three community pharmacies, pleaded guilty to charges involving approximately 1,443,000 tablets of controlled substances such as Diazepam and Zopiclone. This conduct led to a 28-month imprisonment sentence.
During the hearing, the registrant expressed remorse and acknowledged the severity of his actions, which posed a significant risk to public safety and brought the pharmacy profession into disrepute. Despite the registrant’s remorse and some insight into his misconduct, the Committee found that he had not yet demonstrated sufficient remediation or insight to warrant a return to practice. The registrant’s health issues, including Bipolar Affective Disorder, were considered, but the Committee emphasized the need for further evidence of remediation and insight.
The GPhC determined that the registrant’s fitness to practise remains impaired, and a 12-month suspension with a review was deemed appropriate to protect the public and maintain confidence in the profession. The Committee outlined guidance for the registrant, suggesting steps such as continued engagement with the Council, obtaining health reports, and undertaking relevant courses to demonstrate remediation and readiness for a potential return to practice.
This case serves as a critical reminder for pharmacy professionals about the importance of adhering to legal and ethical standards, particularly concerning the handling of controlled substances. It underscores the need for pharmacists to maintain integrity and public trust, and highlights the severe consequences of breaching these standards.
Original Case Document
The full determination transcript is available to logged in users.
Log in or register for free to access.